INTRODUCTION
White adipose tissue (WAT) is a highly dynamic organ that responds to nutrient and environmental stress (Berry et al., 2014; Rosen and Spiegelman, 2006; Rosen and Spiegelman, 2014; Zeve et al., 2009) . When mammals are in positive energy balance, WAT expands by hyperplasia and hypertrophy to store excess nutrients. In contrast, prolonged cold stress induces catabolic programs in WAT depots, in particular in the subcutaneous WAT (scWAT) of mice, to support thermogenesis (Harms and Seale, 2013; Wu et al., 2013) . In this case, adrenergic stimulation of scWAT promotes tissue ''browning'' via induction of beige adipocytes that express the uncoupling protein 1 (UCP1). This de novo recruitment of beige adipocytes alleviates cold stress to restore thermal homeostasis (Nedergaard and Cannon, 2014) . Despite progress in this field, the physiologic signals that regulate adipocyte precursor proliferation and their subsequent commitment to the beige adipocyte lineage remain poorly understood.
Fate mapping studies have led to the identification of progenitor or precursor cell populations that give rise to brown and beige adipocytes in adult mice. These studies have revealed that interscapular brown adipocytes arise from a mesodermal progenitor that transiently expresses the myogenic transcription factors Myf5 and Pax7 (Lepper and Fan, 2010; Seale et al., 2008) . In contrast, beige adipocytes, which are found in WAT depots of mice, primarily arise from Myf5 À PDGFRa + precursor cells (Sanchez-Gurmaches et al., 2012; Seale et al., 2008) . Fate mapping studies by the Granneman laboratory have elegantly demonstrated that pharmacologic activation of the b3-adrenergic receptor stimulates the proliferation of PDGFRa + precursor cells, which subsequently differentiate into beige adipocytes (Lee et al., 2012) . Interestingly, these PDGFRa + precursor cells can also give rise to white adipocytes in the setting of dietary obesity (Berry and Rodeheffer, 2013; Hudak et al., 2014; Lee et al., 2012; Wang et al., 2014) , suggesting that environmental signals likely dictate the commitment of PDGFRa + precursor cells to the beige or white adipocyte lineage. Exposure of adult animals to environmental cold stimulates the growth of thermogenic beige fat via activation of adrenergic signaling pathways (Harms and Seale, 2013; Wu et al., 2013) . In contrast to interscapular BAT, we recently reported that the scWAT relies on a hematopoietic circuit consisting of eosinophils and alternatively activated macrophages for the maintenance of its adrenergic tone. In response to environmental cold, we found that eosinophil-derived interleukin (IL)-4 induces the expression tyrosine hydroxylase (TH), the rate-limiting enzyme in the synthesis of catecholamines, in alternatively activated macrophages (Nguyen et al., 2011; Qiu et al., 2014) . Accordingly, genetic deletion of Il4ra or Th in myeloid cells significantly impaired the development of thermogenic beige fat in mice (Qiu et al., 2014) . The observation that other browning factors, such as meteorin-like (METRNL) also utilize this pathway for their thermic effects (Rao et al., 2014) , suggests that type 2 innate immunity might be integrally linked with the development of beige adipose tissue.
ILC2s, which are present in lymphoid and nonlymphoid tissues (Moro et al., 2010; Neill et al., 2010; Price et al., 2010) , orchestrate type 2 innate and adaptive immune responses in the setting of tissue damage, helminth infection, and allergen exposure (Koyasu and Moro, 2013; McKenzie et al., 2014; Walker et al., 2013) . In these scenarios, the release of epithelial cellderived cytokines IL-33, IL-25, and thymic stromal lymphopoietin (TSLP) results in the activation of ILC2s, which then secrete IL-5 and IL-13 to initiate type 2 immune responses (Cayrol and Girard, 2014; Licona-Limó n et al., 2013) . For instance, in the absence of ILC2s or IL-4/13, the allergen chitin is unable to promote recruitment of eosinophils or alternatively activated macrophages in the lungs (Van Dyken et al., 2014) . In addition to their functions in immunity at mucosal sites, ILC2s have been identified in epididymal WAT (eWAT) of mice, where they sustain eosinophils and alternatively activated macrophages to promote glucose homeostasis . Since ILC2-derived IL-5 and IL-13 are critical for initiating type 2 immune responses, we asked whether these cells might also orchestrate the development of beige fat in mice.
Here, we report that administration of IL-33 results in accumulation and activation of ILC2s in the scWAT of mice to stimulate biogenesis of functional beige fat. Surprisingly, in an IL-4/13-dependent manner, IL-33 stimulates the proliferation of PDGFRa + adipocyte precursor cells, which then commit to the beige adipocyte lineage. The dependence of APs on IL-4/13 signaling for their expansion and commitment to beige adipocytes is not restricted to their pharmacological activation by IL-33 but is also observed during normal physiologic development of this tissue.
RESULTS

IL-33 Promotes Growth of Functional Beige Fat in Thermoneutral Mice
To investigate the functions of ILC2s in beige fat development, we intraperitoneally administered IL-33 to thermoneutral mice daily for 8 days to activate tissue resident ILC2s. In a dosedependent manner, administration of IL-33 led to a robust increase in the expression of UCP1 protein in the scWAT of thermoneutral C57BL/6J mice ( Figures 1A and 1B) , suggesting that IL-33 stimulates the growth of beige fat. This browning of scWAT by IL-33 was comparable in magnitude to that induced by the type 2 cytokines IL-4 or IL-13 ( Figure 1C ), which previously have been implicated in the development of beige fat (Qiu et al., 2014; Rao et al., 2014) . Histologic analysis confirmed the presence of multilocular beige adipocytes in the scWAT of mice treated with IL-33 ( Figures 1D and 1E ). In contrast to browning of scWAT, administration of IL-33, IL-13, or IL-4 did not alter the expression of UCP1 protein in the interscapular brown adipose tissue (BAT) of thermoneutral mice ( Figure 1C ). Together with our previous studies, these results demonstrate a selective role for type 2 cytokines in stimulating beige fat development. Next, we asked whether IL-33-induced browning of scWAT contributes to whole-body energy expenditure. To test this postulate, we quantified energy expenditure in vehicle-and IL-33-treated mice at different environmental temperatures. Although energy expenditure was similar in vehicle-and IL-33-treated mice at thermoneutrality (30 C), animals treated with IL-33 had higher energy expenditure ($13%-17%) at the cooler housing temperatures ( Figures 1F and 1G ), which likely reflects activation of recruited beige fat. Moreover, these results are consistent with the previous reports demonstrating that beige fat thermogenesis is stimulated by cold exposure in both mice and humans (Qiu et al., 2014; van der Lans et al., 2013; Yoneshiro et al., 2013) . Based on these results, we next investigated whether IL-33 increases energy expenditure in a UCP1-dependent manner. For these experiments, thermoneutral C57BL/6J and congenic Ucp1 À/À mice were administered IL-33 for 8 days ( Figure 1A ), and oxygen consumption was quantified after injection of norepinephrine (NE). Administration of NE, which activates all adrenoreceptors to maximally stimulate thermogenesis (Golozoubova et al., 2006) , transiently increased oxygen consumption in thermoneutral C57BL/6J mice ( Figure 1H ). This NE-stimulated increase in metabolic rate was markedly enhanced in C57BL/6J mice that were administered IL-33 ( Figure 1H ). Importantly, IL-33-induced increase in oxygen consumption was completely absent in Ucp1 À/À mice ( Figure 1I ), indicating that IL-33-induced recruitment of beige fat is critical for increasing the total thermogenic capacity of these mice.
IL-33 Stimulates Proliferation and Commitment of Adipocyte Precursors to the Beige Fat Lineage
To uncover the mechanisms by which IL-33 promotes browning of scWAT, we characterized the immune and precursor populations present in the scWAT of mice. For these studies, we used heterozygous Red5 (Il5 Red5/+ , R5) mice, which express tandem dimer red fluorescent protein (tdTomato) from the translation initiation site of the endogenous Il5 locus , to monitor the fate and activation of ILC2s. ILC2s residing in the scWAT of mice were identified as being Lin Wu et al., 2012) . We found that treatment with IL-33 increased the expression of TMEM26 and CD137 on the cell surface of PDGFRa + APs ( Figures 2F, 2G , S2C, and S2D), suggesting that IL-33 enhances the growth of beige fat by altering the proliferative and differentiation potential of scWAT APs.
We next investigated the signaling pathways by which IL-33 stimulates the expansion of APs. We hypothesized that IL-33 itself or factors secreted by IL-33 activated ILC2s, such as IL-5 (legend continued on next page) or IL-13 (Koyasu and Moro, 2013; McKenzie et al., 2014; Walker et al., 2013) , directly stimulate the proliferation of PDGFRa + APs. Flow cytometric analysis revealed that PDGFRa + APs did not express the receptors required for signaling by IL-33 (IL1RL1) or IL-5 (IL-5Ra), but they did express IL-4Ra ( Figures 2H-2J and S2E), which is required for both IL-13 and IL-4 signaling (Kelly-Welch et al., 2003) . These observations led us to hypothesize that secretion of IL-13 by activated ILC2s or IL-4 by recruited eosinophils might support the proliferative burst of APs. We first tested the requirement for IL-5 in IL-33 stimulated AP proliferation. Albeit to a slightly lower extent than in WT mice, stimulation with IL-33 enhanced AP proliferation in R5R5 (Il5 Red5/Red5 ) homozygous mice (Figure S2F) , which lack the eosinophil growth factor IL-5 but can secrete IL-13 upon activation ( Figures S1D and S2G ). Since eosinophils are an important source of IL-4 in WAT (Qiu et al., 2014; Wu et al., 2011) , we next tested their requirement in IL-33-mediated AP proliferation. Figure S2H shows that IL-33 was equally efficacious in stimulating expansion of scWAT APs in eosinophil-deficient DdblGATA mice (Yu et al., 2002) , suggesting potential redundancy between eosinophil-derived IL-4 and ILC2-dervied IL-13 in mediating this response. 2L ). A similar requirement for type 2 cytokine signaling was observed in IL-33-mediated browning of scWAT, as monitored by the expression of UCP1 protein in the scWAT of thermoneutral WT and Il4ra À/À mice administered IL-33 ( Figure 2M ).
Together, these findings establish a hierarchy between ILC2s, eosinophils, and signaling via the IL-4Ra in the regulation of AP biology. To test whether the stimulatory effects of IL-33 on AP proliferation and commitment require ILC2s, we administered IL-33 to Rag2 À/À and Rag2Il2rg À/À mice, the latter known to lack ILC2s (Price et al., 2010) . While IL-33 increased AP proliferation in Rag2 À/À mice, it failed to do so in Rag2Il2rg À/À mice ( Figure 2N ), indicating an absolute requirement for ILC2s in IL-33-mediated expansion of scWAT APs. Similarly, the induction of beige adipocyte markers, TMEM26 and CD137, by IL-33 was only observed in Rag2 À/À mice ( Figures 2O, 2P , S2I, and S2J), suggesting that ILC2s are the likely target for IL-33-induced browning of scWAT.
Physiologic Expansion of Adipocyte Precursors Is Controlled by Type 2 Cytokine Signaling
Since pharmacologic activation of ILC2s promoted proliferation of adipogenic precursors in an IL-4/13-dependent manner, we next asked whether these signals might control the physiologic expansion of APs during the postnatal period. We first quantified the proliferative status of PDGFRa
APs in the scWAT of C57BL/6J mice at various ages (Figures S3A and S3B) . We found that proliferation of scWAT APs, as assessed by intracellular staining for the cell proliferation antigen Ki67, was age dependent ( Figure 3A ). Approximately 5.8% of scWAT APs stained positive for Ki67 in 4-week-old mice, which declined by 85% and 95%, respectively, in the scWAT of 8-and 12-week-old mice ( Figure 3A ). BrdU incorporation experiments provided independent verification for this age-associated decline in DNA synthesis and AP proliferation ( Figure 3B ). We next asked whether type 2 immunity regulates this postnatal expansion of APs in the WAT. In support of our hypothesis, we observed an age-associated decline in type 2 cytokine signaling in APs, as assessed by the phosphorylation status of signal transducer and activator of transcription 6 (STAT6), which mediates the biological effects of type 2 cytokines IL-4 and IL-13 ( Figure 3C ) (Kelly-Welch et al., 2003) . Using 4get mice, which express green fluorescent protein (GFP) from the Il4 locus (Mohrs et al., 2001) , we next asked whether the number of cells competent for IL-4 production in scWAT changes with age. Congruent with the decrease in levels of pSTAT6 (Figure 3C) , the scWAT of 9-week-old mice had $70% fewer GFP + cells. This decrease in GFP + cells primarily reflected a decline in the numbers of resident eosinophils ( Figure S3C ), which have previously been implicated in secretion of IL-4 in scWAT and eWAT (Qiu et al., 2014; Wu et al., 2011) . Furthermore, this reduction in numbers of GFP + eosinophils was associated with a $70% decrease in proliferation (Ki67 positivity) and a $50% reduction in numbers of APs present in the scWAT (Figures S3D and S3E) . A similar age-associated decline in proliferation of APs was observed in the scWAT and eWAT of BALB/cJ mice (Figures S3F and S3G) , suggesting that this is not a strainspecific effect. Finally, this age-associated decrease in AP proliferation was not a consequence of changes in expression of PDGFRa or IL-4Ra on the cell surface of APs (Figures S3H and S3I) . Based on these results, we next asked whether loss of type 2 cells or signals affects AP proliferation and numbers in the scWAT. For these studies, we focused on 5-week-old mice because we observed robust proliferation of APs at this age in both C57BL/6J and BALB/cJ mice. Consistent with our hypothesis, DdblGATA mice, which lack eosinophils, had $30% fewer APs in their scWAT with $70% lower proliferative fraction (Figures 3E and 3F) . Il4/13 À/À mice, which lack the type 2 cytokines IL-4 and IL-13, also demonstrated decreases in scWAT AP proliferation ($56%) and numbers ($70%) ( Figures 3G and 3H) . Similarly, deletion of the IL-4/13 signaling subunit Il4ra decreased the percentage of Ki67 + APs by $48% and their numbers by $52% in scWAT ( Figures 3I and 3J ). In aggregate, these data suggest that signaling via the IL-4Ra accounts for $50% of the proliferative capacity of APs in the scWAT of mice, prompting us to investigate the mechanisms by which type 2 immunity instructs the postnatal development and functions of this adipose depot. ) mice that were administered vehicle (Veh) or IL-33 for 8 days. Expression of IL-5 (td Tomato) from the Red5 allele was used as a marker of ILC2 activation (n = 9-10 per treatment).
(legend continued on next page)
IL-4Ra Signaling in PDGFRa + Cells Promotes Expansion of Adipocyte Precursors
Previous studies by the Granneman laboratory have demonstrated that pharmacologic activation of the b3-adrenergic receptor stimulates the proliferation and differentiation of APs into beige adipocytes (Lee et al., 2012 ). Since we recently demonstrated that type 2 activation of macrophages via IL4Ra stimulates release of norepinephrine in the scWAT and eWAT of mice (Nguyen et al., 2011; Qiu et al., 2014) , we next asked whether myeloid cell IL-4Ra signaling might regulate the postnatal expansion and commitment of APs to the beige adipocyte lineage. To our surprise, we found that deletion of Il4ra in mice). Consistent with the loss of IL-4Ra expression in APs (Figure S4C ), IL-4 stimulated increase in pSTAT6 was reduced by $80% in scWAT APs, but not in the CD11b + myeloid cells, of Il4-ra f/f Pdgfra Cre mice ( Figures 4B, S4D , and S4E). Consequently, both the proliferative capacity of APs and their numbers were reduced by $54% and $43%, respectively, in 5-week-old Il4-ra f/f Pdgfra Cre mice ( Figures 4C and 4D ). These results indicate that the type 2 cytokines IL-4 and IL-13 play a critical role in controlling adipocyte precursor pool size by directly activating IL-4Ra signaling in PDGFRa + APs.
To investigate whether pharmacological activation of IL-4Ra signaling is sufficient to stimulate the proliferation of APs in scWAT, we injected 8-to 10-week-old mice with IL-4 as a complex with anti-IL4 antibody, which prolongs its biological half-life (Finkelman et al., 1993 ). As noted above, the rate of AP proliferation declines with age ( Figures 3A and 3B) ; however, this was restored by the administration of IL-4 to WT mice. For instance, treatment of 8-to 10-week-old mice with IL-4 complex increased the percentage of Ki67 + APs by $5.5-7.5-fold within 24-48 hr ( Figure 4E ). This stimulation of AP proliferation by IL-4 or IL-13 was an on-target effect of these cytokines because it required IL-4Ra ( Figures 4F and  4G) . Furthermore, administration of IL-4 complex failed to stimulate DNA synthesis or cellular proliferation in APs of Il4ra f/f Pdgfra Cre mice ( Figures 4H and S4F ), confirming that IL-4 stimulates the growth of APs in a cell autonomous manner. After 48 hr, the number of APs present in scWAT also increased by $2.5-fold, demonstrating that stimulation with IL-4 is sufficient to expand the pool of PDGFRa + APs that reside within scWAT ( Figures 4I and S4G) . Again, this increase in AP number was dependent on cell autonomous signaling via the IL-4Ra in PDGFRa + cells ( Figure 4I ). Purification of APs from wild-type,
Il4ra
À/À , and Stat6 À/À mice provided independent verification for the direct proliferative effects of IL-4 on APs ( Figures S4H,  S4I , and 4J). Finally, we tested whether IL-33-induced proliferation of APs requires cell autonomous signaling via the IL-4Ra. Indeed, while IL-33 robustly induced AP proliferation ($19-fold) in the scWAT of Il4ra f/f mice, it failed to do so in Il4ra f/f Pdgfra Cre mice ( Figure 4K ). In a similar manner, the induction of IL-4Ra and beige adipocyte markers (TMEM26 and CD137) by IL-33 was absent in Il4ra f/f Pdgfra Cre mice (Figures S4J-S4L ). In aggregate, these results demonstrate that the IL-33/ILC2/IL4Ra signaling pathway acts directly on scWAT APs to expand the pool of beige adipogenic precursors.
IL-4 and IL-13 Direct Commitment of PDGFRa + Adipocyte Precursors to Beige Adipogenic Precursors
PDGFRa + APs present in scWAT are bipotential cells that can give rise to white or beige adipocytes (Berry et al., 2014; Lee et al., 2012) , prompting us to ask whether signaling via the IL-4Ra might direct the commitment of APs to either lineage. Using purified wild-type APs from the scWAT, we first investigated the effects of IL-4 on their adipogenic conversion into white adipocytes. Figures S5A-S5C show that the addition of IL-4 during the initial differentiation period inhibited the conversion of APs into white adipocytes. Since differentiated adipocytes did not express IL4Ra at any appreciable level ( Figure S5C ), we hypothesized that the biologic actions of type 2 cytokines might be restricted to adipogenic precursors. We thus asked whether, in the absence of adipogenic stimuli, treatment with IL-4 altered the fate of purified APs. Indeed, in a time-dependent manner, treatment of purified APs with IL-4 induced the expression of a number of beige adipocyte makers, including Klhl13, Ear2, Tmem26, and Tnfrsf9 (Figure 5A) . Consistent with the distinct developmental lineages of beige and brown adipocytes (Harms and Seale, 2013) , exposure to IL-4 did not alter the expression of brown fat markers in APs purified from scWAT ( Figure S5D ). This commitment of APs to the beige fat lineage was an on-target effect of IL-4 because it was absent in APs isolated from Il4ra À/À mice ( Figure 5B ).
We next asked whether administration of IL-4 to wild-type mice was sufficient to promote the expression of beige lineage markers in APs. Cell surface expression of IL-4Ra, a known target of IL-4/ STAT6 signaling (Goenka and Kaplan, 2011) , and the beige precursor markers CD137 (encoded by Tnfrsf9) and TMEM26 were all induced in the scWAT APs upon treatment with IL-4 ( Figures  5C-5H To investigate whether the induction of beige precursor cell markers correlates with enhanced capacity for beige adipogenesis, we pretreated purified APs with IL-4 and then subjected them to beige adipogenic stimuli. Congruent with our hypothesis, we observed that IL-4 pretreated APs exhibited enhanced capacity for beige adipogenesis, as assessed by the expression of UCP1 mRNA and protein ( Figures 5M and 5N) . Moreover, we observed that differentiation of APs into beige adipocytes resulted in downregulation of beige adipocyte markers (Tnfrsf9, Klhl13, and Tmem26) ( Figure S6K ), indicating that these markers might work better for the identification of beige adipocyte precursors rather than the differentiated beige adipocytes in WATs. Together, these in vitro and in vivo data suggest that the activation of signaling via the IL-4Ra in PDGFRa + cells is both required and sufficient to promote the commitment of bipotential APs to the beige fat lineage.
IL-4Ra Signaling in Adipocyte Precursors Controls Growth of Beige Fat
We next asked whether loss of IL-4Ra signaling in PDGFRa + cells alters the development of beige fat in vivo. The browning of scWAT normally occurs when mice experience cold stress. Since the standard vivarium temperature of 20 C-22 C poses a significant thermal stress for young mice (Cannon and Nedergaard, 2011; Nedergaard and Cannon, 2014) , due to their high ratio of body surface area to body mass, we asked whether young (5-week-old) mice exhibited browning of their scWAT. We chose this time point because it represents the peak for scWAT AP IL-4Ra signaling and proliferation ( Figures  3 and 4) . Indeed, we found histological evidence for beige fat with these histological data, immunoblot analysis for UCP1 protein demonstrated its robust expression in the scWAT of Il4ra f/f but not Il4ra f/f Pdgfra Cre mice ( Figure 6B ). In contrast,
we did not observe significant differences among the genotypes in expression of UCP1 protein in interscapular brown adipose tissue ( Figure 6B ), which develops from distinct myogenic precursors (Lepper and Fan, 2010; Seale et al., 2008) .
To investigate whether browning of scWAT in young mice contributed to total body energy expenditure, we studied 5-week-old mice Il4ra f/f and Il4ra f/f Pdgfra Cre mice using the Comprehensive Lab Animal Monitoring Systems (CLAMS). Energy expenditure, as quantified by total oxygen consumption (VO 2 ) per mouse, was significantly lower ($20%-25%) in Il4ra f/f Pdgfra Cre mice in both the day and night cycle ( Figure 6C ).
This reduction in VO2 was unlikely to be a consequence of changes in total locomotor activity, RER, or food intake, which were similar between the two genotypes ( Figure 6D-6F) .
Together, these results demonstrate that IL-4Ra signaling in adipocyte precursor cells is a critical regulator for the development of postnatal beige fat.
IL-4Ra Signaling in Mature Adipocytes Is Dispensable for Growth of Beige Fat
Because adipogenic precursors give rise to mature adipocytes (Berry et al., 2014) , it remains plausible that the metabolic phenotypes observed in Il4ra f/f Pdgfra Cre mice result from loss of IL-4Ra signaling in mature adipocytes. To address this possibility, we generated mice in which the Il4ra gene was selectively deleted in differentiated adipocytes (designated Il4ra f/f Adipoq Cre ). Consistent with its primary role in APs, deletion of Il4ra in mature adipocytes did not affect beige fat development as assessed histologically and by immunoblotting for UCP1 (Figures 7A, 7B and S6L) . Accordingly, Il4ra f/f and Il4ra f/f Adipoq Cre mice had similar rates of oxygen consumption, RER, total activity, and food intake ( Figures 7C-7F ). These findings are consistent with the observations that IL-4Ra is highly expressed in adipogenic precursors but not in mature adipocytes (Figures 5N and S5C) .
DISCUSSION
We have previously demonstrated that exposure to environmental cold induces an innate type 2 response to stimulate the growth of beige fat. This efferent innate circuit consists of IL-4-secreting eosinophils and catecholamine-producing alternatively activated macrophages (Nguyen et al., 2011; Qiu et al., 2014 Pdgfra Cre mice. Taken together with our previous results, these findings suggest that type 2 immunity regulates two key events in the biogenesis of beige fat. First, it controls the expansion and commitment of APs to the beige fat lineage. Second, it stimulates the differentiation of beige precursor cells into beige adipocytes via myeloid cell-derived catecholamines.
Browning of WAT has principally been studied in adult rodents after prolonged exposure to cold (Nedergaard and Cannon, 2014; Wu et al., 2013) . In these experimental paradigms, the housing of adult mice in cold environments (4 C-8 C for 2 days or longer) promotes the emergence of UCP1 + multilocular beige adipocytes. The underlying assumption here has been that prolonged cold exposure creates a mismatch between the organism's capacity for heat generation and its heat loss to the environment, necessitating the recruitment of additional thermogenic tissues to maintain thermal homeostasis (Nedergaard and Cannon, 2014; Qiu et al., 2014) . Because the normal vivarium temperature of 20 C-22 C imposes a significant thermal stress on young mice, in which the ratio of body surface area to body mass is large, we reasoned that it might be a powerful stimulus for the recruitment of UCP1 + beige adipocytes. Indeed, we found histological evidence for browning in the scWAT of 5-week-old mice housed at 20 C-22 C. Unlike the cold-induced browning in adult mice, which is generally patchy and incomplete even within individual lobules, this ''physiologic'' browning of the scWAT in young mice was more widespread, involving entire adjacent lobules ( Figures 6A and 7A) . Thus, we suggest that, as an alternative to the classic experimental paradigm of housing adult mice at 4 C-8 C, investigations of the physiologic browning process in young mice might yield useful insights into the mechanisms that regulate beige fat biogenesis.
Although the stages of scWAT development have been studied previously (Wang et al., 2013) , the physiologic signals that regulate the proliferation and/or fate of scWAT APs were unknown. Our observations that IL-33 potently stimulates proliferation of PDGFRa + APs in an IL-4/13-and IL-4Ra-dependent manner ( Figures 2K and 2L ) led us to investigate whether type 2 cytokines might be the physiologic signals controlling the expansion of PDGFRa + APs in the scWAT. Indeed, we found that loss of type 2 cytokine signaling decreased the proliferation rate and number of PDGFRa + APs by $50% in scWAT. Interestingly, this signaling pathway also regulated the commitment of PDGFRa + APs to the beige adipocyte precursors in a cell autonomous manner. Since the proliferation rate of PDGFRa + APs declines with age ( Figures 3A and 3B) , our results suggest that the activation of type 2 cytokine signaling in the early postnatal period establishes a pool of PDGFRa + beige adipocyte precursors, which are subsequently recruited by cold stress to generate beige adipocytes in the adult organism. Perhaps, these data also provide an explanation for the old observation that thermogenic adaptations to cold decline with aging (Talan et al., 1985) . Our gain-and loss-of-function studies suggest that type 2 innate immune cells have discrete roles in controlling the numbers and fate of PDGFRa + adipocyte precursors in the scWAT of mice. During physiologic development of this tissue, eosinophil-derived IL-4 seems to play a critical role in the homeostatic expansion of PDGFRa + APs into beige adipocyte precursors in young mice ( Figures 3E, 3F , S6G, and S6H). However, IL-33-induced pharmacologic expansion of scWAT APs in adult animals seems to occur independently of eosinophils (Figure S2H ). Since both ILC2s and signaling via the IL-4Ra are required for IL-33-mediated proliferation of scWAT APs and their subsequent differentiation into beige adipocytes ( Figures 2K-2P ), it suggests that secretion of IL-13 by ILC2s might be a dominant mechanism by which this tissue responds to environmental stress. Thus, in the future, it will be critical to examine the requirement of and mechanisms by which ILC2s and IL-33 regulate the development of functional beige fat during cold stress. Finally, together with previous studies, our work provides mechanistic insights into how mammals adapt and acclimatize to environmental cold. During an acute cold challenge, mice defend their core body temperature by quickly activating thermogenesis. This rapid increase in heat production, which occurs within seconds to minutes, is mediated by several thermoeffectors, including cutaneous vasoconstriction, skeletal muscle shivering, and UCP1-mediated respiration in brown adipocytes; processes that are all activated by the sympathetic nervous system (Cannon and Nedergaard, 2011; Lowell and Spiegelman, 2000) . In contrast, prolonged cold stress induces cellular programs for acclimatization, such as the de novo recruitment of beige adipocytes (Harms and Seale, 2013) , which occur on a longer time frame (days to weeks to months) for more stable physiologic adaptations. Although programs of acclimatization are well documented across species and are of great interest to evolutionary biologists, their mechanisms, with a few exceptions (such as changes in skin pigmentation in response to sunlight or increase in oxygen carrying capacity after living at high altitudes), are largely unknown. Through our work, we have identified the mechanism for acclimatization to environmental cold. Unlike the acute adaptations that are initiated by the sympathetic nervous system, acclimatization to environmental cold is orchestrated by type 2 immune cells (ILC2s, eosinophils, and alternatively activated macrophages) and signals (IL-33, IL-4, and -13), which sequentially regulate the expansion, commitment, and differentiation of adipocyte precursors into beige adipocytes. Our identification of the immune system as the primary thermogenic circuit controlling the cold acclimatization process is consistent with a recent proposal that type 2 immunity coevolved as a defensive strategy against noxious environmental stimuli (Palm et al., 2012; Profet, 1991) , of which cold might be one.
EXPERIMENTAL PROCEDURES Animal Studies
All animal studies were conducted at UCSF under an approved IACUC protocol. Mice were housed at 20 C-22 C (unless otherwise stated) in the vivarium under a 12 hr light:dark cycle. Both male and female mice of various ages were used in these studies. The following animal strains were on the BALB/cJ background: WT, Il4/13 Taconic. At the conclusion of experiments, tissues were harvested and snap frozen in liquid nitrogen for molecular analyses, fixed in 10% formalin for histology, or digested for flow cytometric analyses of adipocyte precursors and immune cells. For gain-of-function studies, 8-to 12-week-old mice were injected intraperitoneally with vehicle, IL-33 (0.5-1 mg, Biolegend), IL-13 (0.5 mg, Peprotech), or IL-4 (2 mg, Peprotech) that was complexed with anti-IL4 mAb (10 mg, clone 11B11). Activation of signaling via the IL-4Ra was assessed 1-2 hr after administration of recombinant IL-4 (2 mg). For the in vivo studies, cohorts of R4 mice per genotype or treatment were assembled and experiments were repeated 2-3 independent times.
Statistical Analysis
Data were analyzed using Prism (Graphpad) and are presented as mean ± SEM or mean ± SD. Statistical significance was determined using the unpaired two-tailed Student's t test for single variables and two-way ANOVA followed by Bonferroni posttests for multiple variables. A p value of < 0.05 was considered to be statistically significant and is presented as * (p < 0.05), ** (p < 0.01), or *** (p < 0.001). Extended Experimental Procedures are included in the Supplemental Information. 
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